Skip to main content
Log in

Rectal cancer pelvic recurrence: imaging patterns and key concepts to guide treatment planning

  • Review
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

For rectal cancer, MRI plays an important role in assessing extramural tumor spread and informs surgical planning. The contemporary standardized management of rectal cancer with total mesorectal excision guided by imaging-based risk stratification has dramatically improved patient outcomes. Colonoscopy and CT are utilized in surveillance after surgery to detect intraluminal and extramural recurrence, respectively; however, local recurrence of rectal cancer remains a challenge because postoperative changes such as fat necrosis and fibrosis can resemble tumor recurrence; additionally, mucinous adenocarcinoma recurrence may mimic fluid collection or abscess on CT. MRI and 18F-FDG PET are problem-resolving modalities for equivocal imaging findings on CT. Treatment options for recurrent rectal cancer include pelvic exenteration to achieve radical (R0 resection) resection and intraoperative radiation therapy. After pathologic diagnosis of recurrence, imaging plays an essential role for evaluating the feasibility and approach of salvage surgery. Patterns of recurrence can be divided into axial/central, anterior, lateral, and posterior. Some lateral and posterior recurrence patterns especially in patients with neurogenic pain are associated with perineural invasion. Cross-sectional imaging, especially MRI and 18F-FDG PET, permit direct visualization of perineural spread, and contribute to determining the extent of resection. Multidisciplinary discussion is essential for treatment planning of locally recurrent rectal cancer. This review article illustrates surveillance strategy after initial surgery, imaging patterns of rectal cancer recurrence based on anatomic classification, highlights imaging findings of perineural spread on each modality, and discusses how resectability and contemporary surgical approaches are determined based on imaging findings.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9
Fig. 10
Fig. 11
Fig. 12

Similar content being viewed by others

References

  1. Kapiteijn. E, Marijnen. C. A, Colenbrander. A. C et al (1998) Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol 24:528-535

    Article  CAS  PubMed  Google Scholar 

  2. Allaix ME, Fichera A (2013) Modern rectal cancer multidisciplinary treatment: the role of radiation and surgery. Ann Surg Oncol 20:2921-2928

    Article  PubMed  Google Scholar 

  3. Rasanen M, Carpelan-Holmstrom M, Mustonen H, Renkonen-Sinisalo L, Lepisto A (2015) Pattern of rectal cancer recurrence after curative surgery. Int J Colorectal Dis 30:775-785

    Article  PubMed  Google Scholar 

  4. Yun JA, Huh JW, Kim HC et al (2016) Local recurrence after curative resection for rectal carcinoma: The role of surgical resection. Medicine (Baltimore) 95:e3942

    Article  PubMed  Google Scholar 

  5. Wieldraaijer T, Bruin P, Duineveld LAM et al (2018) Clinical Pattern of Recurrent Disease during the Follow-Up of Rectal Carcinoma. Dig Surg 35:35-41

    Article  PubMed  Google Scholar 

  6. Cai Y, Li Z, Gu X, Fang Y, Xiang J, Chen Z (2014) Prognostic factors associated with locally recurrent rectal cancer following primary surgery (Review). Oncol Lett 7:10-16

    Article  PubMed  Google Scholar 

  7. Farhat W, Azzaza M, Mizouni A et al (2019) Factors predicting recurrence after curative resection for rectal cancer: a 16-year study. World J Surg Oncol 17:173

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lai IL, You JF, Chern YJ et al (2021) The risk factors of local recurrence and distant metastasis on pT1/T2N0 mid-low rectal cancer after total mesorectal excision. World J Surg Oncol 19:116

    Article  PubMed  PubMed Central  Google Scholar 

  9. Palmer G, Martling A, Cedermark B, Holm T (2007) A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 14:447-454

    Article  CAS  PubMed  Google Scholar 

  10. Calvo FA, Sole CV, Rutten HJ et al (2020) ESTRO/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer. Clin Transl Radiat Oncol 24:41-48

    Article  PubMed  PubMed Central  Google Scholar 

  11. Ganeshan D, Nougaret S, Korngold E, Rauch GM, Moreno CC (2019) Locally recurrent rectal cancer: what the radiologist should know. Abdom Radiol (NY) 44:3709-3725

    Article  PubMed  Google Scholar 

  12. Enriquez-Navascues JM, Borda N, Lizerazu A et al (2011) Patterns of local recurrence in rectal cancer after a multidisciplinary approach. World J Gastroenterol 17:1674-1684

    Article  PubMed  PubMed Central  Google Scholar 

  13. Nesbakken A, Nygaard K, Westerheim O, Mala T, Lunde OC (2002) Local recurrence after mesorectal excision for rectal cancer. Eur J Surg Oncol 28:126-134

    Article  CAS  PubMed  Google Scholar 

  14. Sivesgaard K, Larsen LP, Sorensen M et al (2018) Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation. Eur Radiol 28:4735-4747

    Article  PubMed  Google Scholar 

  15. Bouchard P, Efron J (2010) Management of recurrent rectal cancer. Ann Surg Oncol 17:1343-1356

    Article  PubMed  Google Scholar 

  16. Young PE, Womeldorph CM, Johnson EK et al (2014) Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges. J Cancer 5:262-271

    Article  PubMed  PubMed Central  Google Scholar 

  17. Steele SR, Chang GJ, Hendren S et al (2015) Practice Guideline for the Surveillance of Patients After Curative Treatment of Colon and Rectal Cancer. Dis Colon Rectum 58:713-725

    Article  PubMed  Google Scholar 

  18. Heriot AG, Byrne CM, Lee P et al (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51:284-291

    Article  PubMed  Google Scholar 

  19. Benson AB, Venook AP, Al-Hawary MM et al (2018) Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 16:874-901

    Article  PubMed  Google Scholar 

  20. Patel SA, Chen YH, Hornick JL et al (2014) Early-stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection. Dis Colon Rectum 57:449-459

    Article  PubMed  PubMed Central  Google Scholar 

  21. Makhoul R, Alva S, Wilkins KB (2015) Surveillance and Survivorship after Treatment for Colon Cancer. Clin Colon Rectal Surg 28:262-270

    Article  PubMed  PubMed Central  Google Scholar 

  22. Weinstein S, Osei-Bonsu S, Aslam R, Yee J (2013) Multidetector CT of the Postoperative Colon: Review of Normal Appearances and Common Complications. Radiographics 33:515-532

    Article  PubMed  Google Scholar 

  23. Horvat N, Carlos Tavares Rocha C, Clemente Oliveira B, Petkovska I, Gollub MJ (2019) MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management. Radiographics 39:367-387

    Article  PubMed  Google Scholar 

  24. Grosu S, Schafer AO, Baumann T, Manegold P, Langer M, Gerstmair A (2016) Differentiating locally recurrent rectal cancer from scar tissue: Value of diffusion-weighted MRI. Eur J Radiol 85:1265-1270

    Article  PubMed  Google Scholar 

  25. Horvat N, Hope TA, Pickhardt PJ, Petkovska I (2019) Mucinous rectal cancer: concepts and imaging challenges. Abdom Radiol (NY) 44:3569-3580

    Article  PubMed  PubMed Central  Google Scholar 

  26. Pennings JP, de Haas RJ, Murshid KJA, de Jong KP, Dierckx R, Kwee TC (2019) FDG-avid presacral soft tissue mass in previously treated rectal cancer: Diagnostic outcome and additional value of MRI, including diffusion-weighted imaging. Eur J Surg Oncol 45:606-612

    Article  PubMed  Google Scholar 

  27. Rydzak C, Chauhan A, Gupta N, Chuang HH, Rohren EM, Bhosale PR (2016) Fat-Containing Hypermetabolic Masses on FDG PET/CT: A Spectrum of Benign and Malignant Conditions. AJR Am J Roentgenol 207:1095-1104

    Article  PubMed  Google Scholar 

  28. Berger KL, Nicholson SA, Dehdashti F, Siegel BA (2000) FDG PET Evaluation of Mucinous Neoplasms: Correlation of FDG Uptake with Histopathologic Features. Am J Surg Pathol 174:1005-1008

    CAS  Google Scholar 

  29. Dondi F, Albano D, Giubbini R, Bertagna F (2021) 18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review. Nucl Med Commun 42:1293-1300

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Plodeck V, Platzek I, Streitzig J et al (2021) Diagnostic performance of (18)F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer. Abdom Radiol (NY) 46:5086-5094

    Article  PubMed  Google Scholar 

  31. Rokan Z, Simillis C, Kontovounisios C, Moran BJ, Tekkis P, Brown G (2021) Systematic review of classification systems for locally recurrent rectal cancer. BJS Open 5

  32. Suzuki K, Dozois RR, Devine RM et al (1996) Curative reoperations for locally recurrent rectal cancer. Dis Colon Rectum 39:730-736

    Article  CAS  PubMed  Google Scholar 

  33. Jimenez RE, Shoup M, Cohen AM, Paty PB, Guillem J, Wong WD (2003) Contemporary outcomes of total pelvic exenteration in the treatment of colorectal cancer. 46:1619-1625

    Google Scholar 

  34. Kapiteijn E, Marijnen C, Nagtegaal I et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646

    Article  CAS  PubMed  Google Scholar 

  35. Syk E, Torkzad MR, Blomqvist L, Ljungqvist O, Glimelius B (2006) Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer. Br J Surg 93:113-119

    Article  CAS  PubMed  Google Scholar 

  36. Yamada K, Ishizawa T, Niwa T, Chuman Y, Akiba S, Aikou T (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88:988-993

    Article  CAS  PubMed  Google Scholar 

  37. Zhao J, Du CZ, Sun YS, Gu J (2012) Patterns and prognosis of locally recurrent rectal cancer following multidisciplinary treatment. World J Gastroenterol 18:7015-7020

    Article  PubMed  PubMed Central  Google Scholar 

  38. Georgiou PA, Tekkis PP, Constantinides VA et al (2013) Diagnostic accuracy and value of magnetic resonance imaging (MRI) in planning exenterative pelvic surgery for advanced colorectal cancer. Eur J Cancer 49:72-81

    Article  PubMed  Google Scholar 

  39. Sinaei M SC, Milot L, Moghaddam PA, Smith A, Atri M. (2013) Patterns and signal intensity characteristics of pelvic recurrence of rectal cancer at MR imaging. Radiographics 33:E171-187

    Article  PubMed  Google Scholar 

  40. Lord AC, Knijn N, Brown G, Nagtegaal ID (2020) Pathways of spread in rectal cancer: a reappraisal of the true routes to distant metastatic disease. Eur J Cancer 128:1-6

    Article  PubMed  Google Scholar 

  41. Yang Y, Huang X, Sun J et al (2015) Prognostic value of perineural invasion in colorectal cancer: a meta-analysis. J Gastrointest Surg 19:1113-1122

    Article  PubMed  Google Scholar 

  42. Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID (2016) Perineural Invasion is a Strong Prognostic Factor in Colorectal Cancer: A Systematic Review. Am J Surg Pathol 40:103-112

    Article  PubMed  Google Scholar 

  43. Kinugasa T, Mizobe T, Shiraiwa S, Akagi Y, Shirouzu K (2017) Perineural Invasion Is a Prognostic Factor and Treatment Indicator in Patients with Rectal Cancer Undergoing Curative Surgery: 2000-2011 Data from a Single-center Study. Anticancer Res 37:3961-3968

    PubMed  Google Scholar 

  44. Soldatos T, Andreisek G, Thawait GK et al (2013) High-resolution 3-T MR neurography of the lumbosacral plexus. Radiographics 33:967-987

    Article  PubMed  Google Scholar 

  45. Capek S, Howe BM, Amrami KK, Spinner RJ (2015) Perineural spread of pelvic malignancies to the lumbosacral plexus and beyond: clinical and imaging patterns. Neurosurg Focus 39:E14

    Article  PubMed  Google Scholar 

  46. Stone JJ, Adamo DA, Khan DZ et al (2019) Multimodal Imaging Aids in the Diagnosis of Perineural Spread of Prostate Cancer. World Neurosurg 122:e235-e240

    Article  PubMed  Google Scholar 

  47. Havenga K, Grossmann I, DeRuiter M, Wiggers T (2007) Definition of total mesorectal excision, including the perineal phase: technical considerations. Dig Dis 25:44-50

    Article  PubMed  Google Scholar 

  48. Rothlisberger R, Aurore V, Boemke S et al (2018) The anatomy of the male inferior hypogastric plexus: What should we know for nerve sparing surgery. Clin Anat 31:788-796

    Article  PubMed  Google Scholar 

  49. Thawait SK, Chaudhry V, Thawait GK et al (2011) High-resolution MR neurography of diffuse peripheral nerve lesions. AJNR Am J Neuroradiol 32:1365-1372

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Dankbaar JW, Pameijer FA, Hendrikse J, Schmalfuss IM (2018) Easily detected signs of perineural tumour spread in head and neck cancer. Insights Imaging 9:1089-1095

    Article  PubMed  PubMed Central  Google Scholar 

  51. Crimi F, Valeggia S, Baffoni L et al (2021) [18F]FDG PET/MRI in rectal cancer. Ann Nucl Med 35:281-290

    Article  PubMed  PubMed Central  Google Scholar 

  52. Lisle DA, Johnstone SA (2007) Usefulness of muscle denervation as an MRI sign of peripheral nerve pathology. Australas Radiol 51:516-526

    Article  CAS  PubMed  Google Scholar 

  53. Delaney H, Bencardino J, Rosenberg ZS (2014) Magnetic resonance neurography of the pelvis and lumbosacral plexus. Neuroimaging Clin N Am 24:127-150

    Article  PubMed  Google Scholar 

  54. Yang TX, Morris DL, Chua TC (2013) Pelvic exenteration for rectal cancer: a systematic review. Dis Colon Rectum 56:519-531

    Article  PubMed  Google Scholar 

  55. Nguyen DQ, McGregor AD, Freites O et al (2005) Exenterative pelvic surgery--eleven year experience of the Swansea Pelvic Oncology Group. Eur J Surg Oncol 31:1180-1184

    Article  CAS  PubMed  Google Scholar 

  56. Dickey ID, Hugate RR, Jr., Fuchs B, Yaszemski MJ, Sim FH (2005) Reconstruction after total sacrectomy: early experience with a new surgical technique. Clin Orthop Relat Res 438:42-50

    Article  PubMed  Google Scholar 

  57. Kim J (2012) Pelvic exenteration: surgical approaches. J Korean Soc Coloproctol 28:286-293

    Article  PubMed  PubMed Central  Google Scholar 

  58. Sagebiel TL, Faria SC, Aparna B, Sacks JM, You YN, Bhosale PR (2011) Pelvic reconstruction with omental and VRAM flaps: anatomy, surgical technique, normal postoperative findings, and complications. Radiographics 31:2005-2019

    Article  PubMed  Google Scholar 

  59. Mishra N (2018) Locally Recurrent Rectal Cancer. Dis Colon Rectum 61:651-654

    Article  PubMed  Google Scholar 

  60. 60 Sagar PM (2014) Ultraradical resection for locally recurrent rectal cancer. Dis Colon Rectum 57:1-2

    Article  PubMed  Google Scholar 

  61. Haddock MG (2017) Intraoperative radiation therapy for colon and rectal cancers: a clinical review. Radiation Oncology 12

    Article  Google Scholar 

  62. Plodeck V, Rahbari NN, Weitz J et al (2019) FDG-PET/MRI in patients with pelvic recurrence of rectal cancer: first clinical experiences. Eur Radiol 29:422-428

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akitoshi Inoue.

Ethics declarations

Conflict of interest

Achille Mileto—Consultant for Bayer Healthcare. Ajit H. Goenka— Others: Research grant from the Champions for Hope Pancreatic Cancer Research Program of the Funk-Zitiello Foundation; Advance the Practice Award from the Department of Radiology, Mayo Clinic, Rochester, Minnesota; CA190188, Department of Defense (DoD), Office of the Congressionally Directed Medical Research Programs (CDMRP); R01CA256969, National Cancer Institute (NCI) of the National Institutes of Health (NIH); Institutional research grant from Sofie Biosciences; Advisory Board (ad hoc), BlueStar Genomics. David H. Bruining– Consulting: Medtronics and Janssen; Research support: Medtronics and Takeda; Helmsley Charitable Trust (grants to institution). Joel G. Fletcher—Siemens Healthcare GmbH (grant to institution); Helmsley Charitable Trust (grants to institution); Pfizer (grant to institution); Boehringer Ingelheim (consulting to institution); Takeda (consulting to institution); Janssen (consulting to institution); Glaxo Smith Kline (consulting to institution). For the remaining authors – none were declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inoue, A., Sheedy, S.P., Wells, M.L. et al. Rectal cancer pelvic recurrence: imaging patterns and key concepts to guide treatment planning. Abdom Radiol 48, 1867–1879 (2023). https://doi.org/10.1007/s00261-022-03746-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-022-03746-4

Keywords

Navigation